Table 3 Lipids & lipoproteins
From: The mixed benefit of low lipoprotein(a) in type 2 diabetes
1st Quartile Lp(a) | Quartiles 2–4 Lp(a) | P | ||
|---|---|---|---|---|
n | 85 | 255 | ~ | |
lipoprotein(a) mean (SD) | nmol.L−1 | 7 (2) | 68 (78) | ~ |
lipoprotein(a) median [IQR] | nmol.L−1 | 6 [5–8] | 38 [15–84] | ~ |
cholesterol | mg.dL−1 | 150 (34) | 155 (33) | NS |
non-HDL-C | mg.dL−1 | 106 (36) | 109 (33) | NS |
LDL-C | mg.dL−1 | 70 (29) | 79 (28) | 0.0114 |
apoB100 | mg.dL−1 | 82 (23) | 84 (21) | NS |
LDL-C. apoB100 −1 | 0.87 (0.28) | 0.95 (0.25) | 0.0207 | |
triglycerides | mg.dL−1 | 199 (194) | 154 (105) | 0.0394 |
HDL-C | mg.dL−1 | 44 (15) | 46 (14) | NS |
apoA-I | mg.dL−1 | 139 (30) | 143 (23) | NS |
atherogenic dyslipidemia | % | 59 | 45 | 0.0332 |
log(TG).HDL-C−1 | 0.06 (0.03) | 0.05 (0.02) | 0.0324 |